PDS Historical Cash Flow
| PDSB Stock | USD 2.25 0.10 4.65% |
Analysis of PDS Biotechnology cash flow over time is an excellent tool to project PDS Biotechnology Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 4 M or Capital Expenditures of 3.8 as it is a great indicator of PDS Biotechnology ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining PDS Biotechnology Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PDS Biotechnology Corp is a good buy for the upcoming year.
PDS |
About PDS Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in PDS balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which PDS's non-liquid assets can be easily converted into cash.
PDS Biotechnology Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Total Cashflows From Investing Activities
The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.Most accounts from PDS Biotechnology's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into PDS Biotechnology Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. At present, PDS Biotechnology's Other Non Cash Items is projected to increase significantly based on the last few years of reporting. The current year's Total Cash From Financing Activities is expected to grow to about 22.8 M, whereas Change In Cash is projected to grow to (16.4 M).
| 2010 | 2023 | 2024 (projected) | Dividends Paid | 270.96 | 243.86 | 216.77 | Cash Flows Other Operating | 873.3K | 4.3M | 2.5M |
PDS Biotechnology cash flow statement Correlations
Click cells to compare fundamentals
PDS Biotechnology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PDS Biotechnology cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 12.1M | 16.7M | 36.4M | 8.6M | (17.3M) | (16.4M) | |
| Stock Based Compensation | 3.2M | 452.3K | 4.1M | 5.2M | 7.6M | 4.4M | |
| Free Cash Flow | (18.1M) | (13.1M) | (12.5M) | (25.7M) | (33.6M) | (35.3M) | |
| Change In Working Capital | (4.6M) | 1.1M | 75.8K | 4.5M | (199.3K) | (189.3K) | |
| Begin Period Cash Flow | 103.7K | 12.2M | 28.8M | 65.2M | 73.8M | 52.7M | |
| Other Cashflows From Financing Activities | 750.0 | 70.5K | 344.1K | (568.9K) | 308.9K | 293.5K | |
| Depreciation | 98.4K | 15.6K | 5.4K | 86.0 | 17.4K | 16.5K | |
| Other Non Cash Items | (9.4M) | 160.7K | 241.0K | 5.5M | 3.8M | 4.0M | |
| Total Cash From Operating Activities | (18.1M) | (13.1M) | (12.5M) | (25.7M) | (33.6M) | (35.3M) | |
| Net Income | (7.0M) | (14.8M) | (16.9M) | (40.9M) | (42.9M) | (45.1M) | |
| Total Cash From Financing Activities | 750K | 29.8M | 48.9M | 34.3M | 16.4M | 22.8M | |
| End Period Cash Flow | 12.2M | 28.8M | 65.2M | 73.8M | 56.6M | 61.8M | |
| Sale Purchase Of Stock | 721.2K | 750K | 29.8M | (270.96) | (243.86) | (231.67) | |
| Investments | (188.7K) | 0.0 | 29.4M | 275.0K | 316.3K | 300.4K | |
| Net Borrowings | 16.7K | (15.6K) | 25M | 24.6M | 28.2M | 15.9M | |
| Change To Operating Activities | (2.6M) | 852.2K | 181.6K | 4.6M | 5.2M | 5.5M | |
| Change To Netincome | (6.6M) | 613.0K | 4.4M | 5.2M | 6.0M | 6.3M | |
| Change To Liabilities | (2.0M) | 217.5K | (105.8K) | 6.0M | 6.9M | 7.3M | |
| Issuance Of Capital Stock | 750K | 29.8M | 48.5M | 9.9M | 16.1M | 19.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PDS Biotechnology. If investors know PDS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PDS Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Return On Assets (0.40) | Return On Equity (1.28) |
The market value of PDS Biotechnology Corp is measured differently than its book value, which is the value of PDS that is recorded on the company's balance sheet. Investors also form their own opinion of PDS Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is PDS Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PDS Biotechnology's market value can be influenced by many factors that don't directly affect PDS Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PDS Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if PDS Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PDS Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.